CompletedNCT01237145

Bronchoalveolar Immune Response Determination

Studying Hypersensitivity pneumonitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bossink, A.W.J.
Principal Investigator: Aik Bossink, MD PhD
Diakonessenhuis, Utrecht
Enrollment: 10 target
Eligibility: 18 years · All sexes
Timeline: 2011 – 2012

Study locations (1)

Diakonessenhuis Utrecht, Utrecht, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01237145 on ClinicalTrials.gov

Other trials for Hypersensitivity pneumonitis

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT06811389
Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
Weill Medical College of Cornell University
RECRUITINGNCT06644144
P4O2 ILD Extension
Amsterdam UMC, location VUmc
RECRUITINGNANCT03800017
Skeletal Muscle Function in Interstitial Lung Disease
University of British Columbia
RECRUITINGNCT05549635
Database and Biobank of Patients With Hypersensitivity Pneumonitis
Nils Hoyer
RECRUITINGEARLY PHASE1NCT05365802
FAPI PET for Lung Fibrosis
University of California, Los Angeles
RECRUITINGNCT05392881
Interstitial Lung Disease Research Unit Biobank
University of Kansas Medical Center
ACTIVE NOT RECRUITINGNCT04844359
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
National Jewish Health
ACTIVE NOT RECRUITINGNCT03747627
BPF Genetics of ILD Study
University of Dundee

See all trials for Hypersensitivity pneumonitis →

← Back to all trials